US 10328130
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
granted A61KA61K31/337A61K38/47
Quick answer
US patent 10328130 (Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions) held by HALOZYME, INC. expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HALOZYME, INC.
- Grant date
- Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/337, A61K38/47, A61P, A61P19/00